PFPG
BIIB icon

Pinnacle Financial Partners (Georgia)’s Biogen BIIB Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Sell
9,892
-33
-0.3% -$6.31K 0.01% 480
2026
Q1 		$1.82M Sell
9,925
-984
-9% -$181K 0.01% 475
2025
Q4 		$1.92M Buy
+10,909
New +$1.78M 0.01% 461

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s BIIB Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its Biogen (BIIB) stake by 0.33% in Q2 2026, selling an estimated $6.31K and leaving 9,892 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #480.

Pinnacle Financial Partners (Georgia) first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 9,892 shares of Biogen worth $2.14M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 33 Biogen shares in Q2 2026, an estimated $6.31K.
  • Biogen made up 0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #480 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.